Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: Improved blood pressure control with bedtime dosinga multicenter, open-label randomized study

Hypertension Research

Volumn 34, Issue 6, 2011, Pages 767-772

  Zeng, Jing ^a,b   Jia, Min ^a,b   Ran, Hua ^c   Tang, Hui ^d   Zhang, Ye ^a,b   Zhang, Jun ^a,b   Wang, Xukai ^a,b   Wang, Hongyong ^a,b   Yang, Chengming ^a,b   Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Cardiology   (China)

^c Department of Cardiology   (China)

^d Department of Cardiology   (China)

Author keywords

amlodipine; chronotherapy; hydrochlorothiazide

Indexed keywords

AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS VALSARTAN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORNING DOSAGE; MULTICENTER STUDY; PILL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TIME; TREATMENT DURATION;

AGED; AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED;

EID: 79958082749     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.36     Document Type: Article

References (36)

1. Lee DE, Cooper RS. Recommendations for global hypertension monitoring and prevention. Curr Hypertens Rep 2009; 11: 444-449.
2. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 2010; 52: 363-382.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303: 2043-2050.
4. Oparil S, Weber M. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy. Postgrad Med 2009; 121: 25-39.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-12052.
6. The World Health Report, 2002. Reducing Risks, Promoting Healthy Life. WorldHealth Organization: Geneva, Switzerland. 2002: 58.
7. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406. (Pubitemid 36350739)
8. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, Kalay N, Topsakal R. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209: 278-282.
9. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: Administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev 2007; 59: 923-939. (Pubitemid 47531897)
10. Nold G, Strobel G, Lemmer B. Morning vs evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 1998; 3: 17-25. (Pubitemid 28181625)
11. Kohno I, Iwasaki H, Okutani M, Mochizuki Y, Sano S, Satoh Y, Ishihara T, Ishii H, Mukaiyama S, Ijiri H, Komori S, Tamura K. Administration-time-dependent effects of diltiazem on the 24-h blood pressure profile of essential hypertension patients. Chronobiol Int 1997; 14: 71-84. (Pubitemid 27119502)
12. Hermida RC, Ayala DE, Mojón A, Chayán L, Doḿnguez MJ, Fontao MJ, Soler R, Alonso I, Fernandez JR. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int 2008; 25: 950-970.
13. Hermida RC, Ayala DE, Fernández JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007; 50: 715-722. (Pubitemid 47442736)
14. Stergiou GS, Nasothimiou EG, Roussias LG. Morning hypertension assessed by home or ambulatory monitoring: different aspects of the same phenomenon? J Hypertens 2010; 28: 1846-1853.
15. Hermida RC, Ayala DE, Fontao MJ, Mojón A, Alonso I, Fernández JR. Administrationtime-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int 2010; 27: 560-574.
16. Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration-timedependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit 2010; 15: 173-180.
17. Mengden T, Binswanger B, Gruene S. Dynamics of drug compliance and 24-h blood pressure control of once daily morning vs evening amlodipine. J Hypertens 1992; 10 (Suppl 4): S136.
18. Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, Hino T, Otsuka Y, Kushiro T, Kanmatsuse K. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol 2004; 43: 68-73. (Pubitemid 38032066)
19. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995; 8: 719-726.
20. Calvo C, Hermida RC, Ayala DE, López JE, Rodŕguez M, Chayán L, Mojón A, Soler R, Fontao MJ, Fernández JR. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin (Barc) 2006; 127: 721-729. (Pubitemid 46034828)
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, National Heart, Lung, and Blood Institute; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
22. Hassler C, Burnier M. Circadian variations in blood pressure: implications for chronotherapeutics. Am J Cardiovasc Drugs 2005; 5: 7-15.
23. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801. (Pubitemid 24363980)
24. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-2189. (Pubitemid 35388236)
25. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, Systolic Hypertension in Europe (Syst-Eur) trial investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-546. (Pubitemid 29380290)
26. Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Fontao MJ, Soler R, Fernández JR. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension 2005; 46: 1053-1059.
27. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999; 100: 1635-1638. (Pubitemid 29477273)
28. Hermida RC, Calvo C, Ayala DE, Doḿnguez MJ, Covelo M, Fernández JR, Mojón A, López JE. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42: 283-290. (Pubitemid 37093474)
29. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, Mito H, Shimada K. Effects of bedtime vs morning administration of the long-acting lipophilic angiotensinconverting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res 2004; 27: 15-20. (Pubitemid 38208417)
30. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 60: 1210-1215. (Pubitemid 15064783)
31. Gould BA, Mann S, Kieso H, Subramanian VB, Raftery EB. The 24-h ambulatory blood pressure profile with verapamil. Circulation 1982; 65: 22-27. (Pubitemid 12250885)
32. Caruana M, Heber M, Brigden G, Raftery EB. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording. Eur J Clin Pharmacol 1987; 32: 549-553. (Pubitemid 17141200)
33. Lonn E, Shaikholeslami R, Yi Q, Bosch J, Sullivan B, Tanser P, Magi A, Yusuf S. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. J Am Coll Cardiol 2004; 43: 2200-2206. (Pubitemid 38757585)
34. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm Jr RH, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group. Results of the controlled onset Verapamil investigation of cardiovascular endpoints (CONVINCE) trial by geographical region. J Hypertens 2005; 23: 1099-1106. (Pubitemid 40637931)
35. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm Jr RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group. Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial. JAMA 2003; 289: 2073-2082. (Pubitemid 37430209)
36. Portaluppi F, Smolensky MH. Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol Int 2010; 27: 1652-1667.